Dexmedetomidine as an Additive for (Ipack)Block in Knee Surgery

Cairo University (CU)

Status: Completed

Conditions: Knee Surgeries

Treatments: Drug: Dexmedetomidine; Drug: Bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT07058493

MS-491-2023

Details and patient eligibility

About

Dexmedetomidine used as an Additive for Ipack Block in Knee Surgery

Full description

Many types of analgesia used but multimodal analgesia showed best results The interspace between the popliteal artery and capsule of the posterior knee (IPACK) block aims to blockade of sciatic nerve terminal branches for analgesia without motor affection

. (IPACK) block is a motor power sparing procedure that involves injecting local anesthetic into the space between the popliteal artery and the posterior capsule of the knee in order to treat posterior knee pain

Enrollment: 40 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18-60 years
• ASA I, II .patients undergoing knee surgeries.

Exclusion criteria

• patient Refusal
• bleeding disorders
• skin lesion
• infection
• known allergy
• contradictions of spinal anesthesia

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Bupivacaine

Experimental group

Description:

IPACK block with 20ml bupivacaine 0.25% alone. .

Treatment:

Drug: Bupivacaine

Dexmedetomidine

Experimental group

Description:

IPACK block with 20 ml of bupivacaine 0.25% with dexmedetomidine 100 μg as adjuvant.

Treatment:

Drug: Dexmedetomidine